VIVO Announces Strategic Investment in Friendly Stranger

NAPANEE, ON, June 20, 2019 /CNW/ – VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) is pleased to announce that it has made a $1.25 million strategic investment in Friendly Stranger Holdings Corp.(“Friendly Stranger”), a longstanding retail champion of cannabis culture. The investment is intended to facilitate Friendly Stranger’s aggressive cannabis retail expansion plans, with a goal of bringing multiple retail stores to the Canadian market.

VIVO is focused on expanding capacity and increasing production capability to help meet the growing demand for cannabis among recreational users. Friendly Stranger has been an iconic brand in the Canadian cannabis sector for more than 25 years and we believe trusted retailers are integral to showcasing our premium family of brands, including Canna Farms™, Fireside™, and Lumina™.

Barry Fishman, Chief Executive Officer of VIVO

We have actively sought strategic partnerships with retailers to establish strong relationships with existing and future leaders in the cannabis industry. We look forward to working with Friendly Stranger to advance their premium adult-use cannabis retail strategy in Ontario and throughout Canada.

“We look forward to welcoming VIVO to the Friendly Stranger family,” said James Jesty, President, Friendly Stranger Holdings Corp.  “With a strategic investment from VIVO, we have additional capital to execute the first phase of our growth strategy to scale and evolve the business. This will include operating several locations fully licenced to sell adult-use cannabis, pending Ontario granting additional licences. VIVO is an ideal partner for us and their line of premium cannabis products aligns well with our brand.”

VIVO Strategic Investment

VIVO has agreed to acquire, through a wholly-owned subsidiary: (i) 187,500 Class A common shares in the capital of Friendly Stranger at a price of $4.00 per share for an aggregate purchase price of $750,000, and (ii) an unsecured convertible debenture of Friendly Stranger in the principal amount of $500,000, for a total investment of $1,250,000. The debenture will bear interest at the rate of 6.0% per annum, have a maturity date of June 19, 2021, and be convertible, at the option of VIVO, into Class A common shares of Friendly Stranger at a conversion price of $5.00 per share, subject to adjustment and certain limitations as provided in the debenture certificate.

VIVO and Friendly Stranger have also entered into a preferred partnership agreement pursuant to which, among other things, the parties have agreed to collaborate on obtaining Friendly Stranger’s cannabis retail licence, conducting in-store events, and leveraging co-branding opportunities.

About Friendly Stranger Holdings Corp:

Established in 1994, Friendly Stranger is Canada’s most iconic cannabis culture shop and is widely revered for its friendly and knowledgeable service.  In 2018, after an initial investment from Green Acre Capital,  Friendly Stranger established Friendly Stranger Holdings Corp (“FSHC”) and announced an expansion plan to open additional retail locations across the country. In 2019, FSHC acquired Happy Dayz and with this merger, FSHC now operates 10 retail locations in Ontariowith over 200,000 customer visits per year. Instagram:  @the_friendly_stranger @happy.dayz420 Twitter: @friendlystrnger @happy_dayz Facebook: Friendlystranger

About VIVO Cannabis™

VIVO, based in Napanee, Ontario, is recognized for trusted, premium cannabis products and services. It holds production and sales licences from Health Canada and operates world-class indoor cultivation facilities with proprietary plant-growing technology at its Canna Farms facility in Hope, B.C., and at its Vanluven facility in Napanee, Ontario. VIVO has a collection of premium brands targeting unique customer segments, including Beacon Medical™, Fireside™, Canna Farms™ and Lumina™. The Company is significantly expanding its production capacity and distribution channels; growing its domestic medical cannabis platform, including Harvest Medicine, its patient-centric, highly scalable network of specialty medical cannabis clinics and services; promoting production and cultivation innovation and pursuing partnership and product development opportunities; and actively focusing on growth in select international markets, including Germany and Australia. VIVO has a healthy balance sheet and is well-positioned to accelerate its growth in Canada and internationally. For more information visit:

Original press release

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter